Work

Effect of concomitant medication use on outcomes of treatment and placebo arms of the COU-AA-301 and COU-AA-302 studies of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e16045

Authors: Robert James Hamilton, Jinhui Li, Vahid Naini, Thian San Kheoh, Peter De Porre, Arturo Molina, Raya Leibowitz-Amit, Johann Sebastian De Bono, Howard I. Scher, Charles J. Ryan, Kim N. Chi, Anthony M. Joshua

Institutions: University of Toronto, Princess Margaret Cancer Centre, Janssen Research & Development (United States), Janssen (Belgium), Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, BC Cancer Agency

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601588864

Cites:

Cited by: 5

Related to: 10